Description

RVD-Hpα, an α-hemoglobin-derived peptide containing three additional amino acids, is a CB1 cannabinoid receptor agonist. RVD-Hpα is a positive allosteric modulator of cannabinoid receptor 2[1][2].—Neuroscience-Neuromodulation–C65H105N19O17—-[1]Ivone Gomes, et al. Novel endogenous peptide agonists of cannabinoid receptors. FASEB J. 2009 Sep;23(9):3020-9.|[2]Fengmei Wei, et al. Hemoglobin-derived peptides and mood regulation. Peptides. 2020 Feb 15;127:170268.–1193362-76-3–1424.65—-N=C(N)NCCC[C@H](N)C(N[C@@H](C(C)C)C(N[C@@H](CC(O)=O)C(N1[C@@H](CCC1)C(N[C@@H](C(C)C)C(N[C@@H](CC(N)=O)C(N[C@H](C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@H](C(O)=O)CC2=CN=CN2)=O)=O)=O)=O)=O)CC3=CC=CC=C3)=O)=O)=O)=O)=O)=O–Neurological Disease–10 mM in DMSO–Cannabinoid Receptor–CB1–GPCR/G Protein;Neuronal Signaling–Peptides